This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe
Save the date!
November 6–8, 2023Munich, Germany

PeLeMed

Profile

PeLeMed is a biotech company discovering new innovative drugs for incurable diseases. Currently we are focusing on drug resistant Oncology and viral infectious diseases. We have 7 R&D pipelines which are promising and potent, and we acquired 1 IND approval (PLM-401) and 1 non clinical trial (PLM-102) is ongoing.

- The investment stage is Series A bridge funding.- PeLeMed has achieved 11 government funds and programs.